Pds biotechnology joins russell microcap® index

Florham park, n.j., july 01, 2021 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb), a clinical-stage immunotherapy company developing novel cancer therapies based on the company's proprietary versamune® t-cell activating technology, was added to the russell microcap® index at the conclusion of the 2021 russell indexes annual reconstitution, effective on june 28, according to the ftse russell website.
PDSB Ratings Summary
PDSB Quant Ranking